Sintilimab: A Promising Anti-Tumor PD-1 Antibody

Zhang, L; Mai, WQ; Jiang, WY; Geng, Q

Jiang, WY; Geng, Q (corresponding author), Wuhan Univ, Dept Thorac Surg, Renmin Hosp, Wuhan, Peoples R China.

FRONTIERS IN ONCOLOGY, 2020; 10 ():

Abstract

Sintilimab (Tyvyt(R)) is a monoclonal antibody against programmed cell death protein 1 (PD-1). It could block the interaction between PD-1 and its lig......

Full Text Link